Clinical Trials Logo

Cancer Cervix clinical trials

View clinical trials related to Cancer Cervix.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03420157 Completed - Cancer Cervix Clinical Trials

Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).

APACHE-4/FG
Start date: January 24, 2018
Phase:
Study type: Observational

Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are not screened or not often enough (nearly 7 millions women). It is therefore necessary to develop new strategies to reach these women. The etiological factor of this cancer is persistent infection with oncogenic High-Risk Human PapillomaVirus (HR-HPV). Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that vaginal self-sampling with HPV test is a powerful means to increase the participation rate in cervical cancer screening. The investigators hypothesize that it is possible to optimize participation rate by improving the communication media associated to the vaginal self-sampling kit. This is why the accompanying letter and the leaflet explaining how to perform the vaginal self-sampling will be submit to women opinion by using the Focus Group method. The objective is to identify improvement ideas of these two communication media.

NCT ID: NCT02255084 Completed - Cancer Cervix Clinical Trials

Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women

APACHE-3
Start date: February 2015
Phase: N/A
Study type: Interventional

Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are not screened or not often enough (nearly 7 millions women). It is therefore necessary to develop new strategies to reach these women. The etiological factor of this cancer is persistent infection with High-Risk Human PapillomaVirus oncogene (HR-HPV). Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that vaginal self-sampling with HPV test is a powerful means to increase the participation rate in cervical cancer screening.

NCT ID: NCT01279135 Completed - Cancer Cervix Clinical Trials

Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix

PARCER
Start date: January 1, 2011
Phase: Phase 3
Study type: Interventional

The study tests Tomtherapy based Image Guided Radiation against conventional radiation techniques for it's ability to reduce long term small bowel toxicity.